That was my exact point Minimoke, long term is the ideal scenario.
A2 has more than enough capacity to handle all the needs for Chinese and US markets ( and the rest of us esp Aust, NZ, South Korea)
FDA Approval, page-3
-
- There are more pages in this discussion • 316 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add A2M (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$6.75 |
Change
0.030(0.45%) |
Mkt cap ! $4.879B | |||
| Open | High | Low | Value | Volume |
| $6.74 | $6.83 | $6.68 | $14.43M | 2.140M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 6761 | $6.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $6.77 | 13253 | 4 |
View Market Depth
| Last trade - 16.10pm 18/06/2024 (20 minute delay) ? |
| A2M (ASX) Chart |